BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis

Journal of Affective Disorders

Volumn 174, Issue , 2015, Pages 432-440

  Polyakova, Maryna ^a,b   Stuke, Katharina ^a   Schuemberg, Katharina ^a   Mueller, Karsten ^a   Schoenknecht, Peter ^b   Schroeter, Matthias L ^a,b  

^a MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; PHARMACOLOGICAL BIOMARKER;

BIPOLAR DISORDER; CROSS-SECTIONAL STUDY; HUMAN; INFORMATION RETRIEVAL; LONGITUDINAL STUDY; MAJOR DEPRESSION; MEASUREMENT; META ANALYSIS; PROTEIN BLOOD LEVEL; PUBLISHING; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE; BLOOD; CYCLOTHYMIC DISORDER; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS; METABOLISM; PLASMA; SERUM;

ANTIDEPRESSIVE AGENTS; BIOMARKERS, PHARMACOLOGICAL; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLOTHYMIC DISORDER; DEPRESSIVE DISORDER, MAJOR; HUMANS; PLASMA; SERUM;

EID: 84920116533     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.11.044     Document Type: Review

References (72)

1. retrieved from 30.01.2014 from http://www.nimh.nih.gov/. The Numbers Count: Mental Disorders in America.
2. A.E. Autry, and L.M. Monteggia Brain-derived neurotrophic factor and neuropsychiatric disorders Pharmacol. Rev. 64 2012 238 258
3. O. Aydemir, A. Deveci, and F. Taneli The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study Prog. Neuropsychopharmacol. Biol. Psychiatry 29 2005 261 265
4. I.G. Barbosa, R.B. Huguet, V.A. Mendonca, F.S. Neves, H.J. Reis, M.E. Bauer, Z. Janka, A. Palotas, and A.L. Teixeira Increased plasma levels of brain-derived neurotrophic factor in patients with long-term bipolar disorder Neurosci. Lett. 475 2010 95 98
5. A.D. Basterzi, K. Yazici, E. Aslan, N. Delialioglu, B. Tasdelen, S.T. Acar, and A. Yazici Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients Prog. Neuro-Psychopharmacol. Biol. Psychiatry 33 2009 281 285
6. M. Bauer, T. Bschor, A. Pfennig, P.C. Whybrow, J. Angst, M. Versiani, H.-J. Moeller, and W.T.F. Unipolar World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care World J. Biol. Psychiatry 8 2007 67 104
7. L. Bocchio-Chiavetto, V. Bagnardi, R. Zanardini, R. Molteni, M.G. Nielsen, A. Placentino, C. Giovannini, L. Rillosi, M. Ventriglia, M.A. Riva, and M. Gennarelli Serum and plasma BDNF levels in major depression: a replication study and meta-analyses World J. Biol. Psychiatry 11 2010 763 773
8. M. Borenstein, L.V. Hedges, and J.P.T. Higgins Comprehensive Meta Analysis, 2.2.064 2009 Wiley Englewood, NJ, USA
9. C.R. Bramham, and E. Messaoudi BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis Prog. Neurobiol. 76 2005 99 125
10. A.R. Brunoni, M. Lopes, and F. Fregni A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression Int. J. Neuropsychopharmacol. 11 2008 1169 1180
11. B.A. Bus, M.L. Molendijk, I. Tendolkar, B.W. Penninx, J. Prickaerts, B.M. Elzinga, and R.C. Voshaar Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time Mol. Psychiatry 2014 (epub ahead of print: PMID: 25155878)
12. B.A.A. Bus, M.L. Molendijk, B.J.W.H. Penninx, J.K. Buitelaar, G. Kenis, J. Prickaerts, B.M. Elzinga, and R.C.O. Voshaar Determinants of serum brain-derived neurotrophic factor Psychoneuroendocrinology 36 2011 228 239
13. S.M. Chang The agency for healthcare research and quality (AHRQ) effective health care (EHC) program methods guide for comparative effectiveness reviews: keeping up-to-date in a rapidly evolving field J. Clin. Epidemiol. 64 2011 1166 1167
14. R.T. de Sousa, M.T. van de Bilt, B.S. Diniz, R.B. Ladeira, L.V. Portela, D.O. Souza, O.V. Forlenza, W.F. Gattaz, and R. Machado-Vieira Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study Neurosci. Lett. 494 2011 54 56
15. A. Delini-Stula, E. Holsboer-Trachsler, T.H. Mikoteit, U. Hemmeter, J. Beck, and A. Eckert BDNF changes during antidepressant treatment: the predictive value for therapeutic outcome Eur. Neuropsychopharmacol. 22 2012 S234 S235
16. M. Deuschle, M. Gilles, B. Scharnholz, F. Lederbogen, U.E. Lang, and R. Hellweg changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment Pharmacopsychiatry 46 2013 54 58
17. B. Dierckx, W.T. Heijnen, W.W. van den Broek, and T.K. Birkenhager Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis Bipolar Disord. 14 2012 146 150
18. N. Dreimuller, K.F. Schlicht, S. Wagner, D. Peetz, L. Borysenko, C. Hiemke, K. Lieb, and A. Tadic Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression Neuropharmacology 62 2012 264 269
19. R.S. Duman, and L.M. Monteggia A neurotrophic model for stress-related mood disorders Biol. Psychiatry 59 2006 1116 1127
20. S. Duval, and R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
21. A.E. Edling, T. Nanavati, J.M. Johnson, and V.K. Tuohy Human and murine lymphocyte neurotrophin expression is confined to B cells J. Neurosci. Res. 77 2004 709 717
22. B. Elfving, P.H. Plougmann, and G. Wegener Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions J. Neurosci. Methods 187 2010 73 77
23. B.S. Fernandes, M. Berk, C.W. Turck, J. Steiner, and C.A. Goncalves Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis Mol. Psychiatry 19 2014 750 751
24. B.S. Fernandes, C.S. Gama, K.M. Cereser, L.N. Yatham, G.R. Fries, G. Colpo, D. de Lucena, M. Kunz, F.A. Gomes, and F. Kapczinski Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis J. Psychiatr. Res. 45 2011 995 1004
25. B.S. Fernandes, C.S. Gama, M. Kauer-Sant'Anna, M.I. Lobato, P. Belmonte-de-Abreu, and F. Kapczinski Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis J. Psychiatr. Res. 43 2009 1200 1204
26. H. Fujimura, C.A. Altar, R. Chen, T. Nakamura, T. Nakahashi, J. Kambayashi, B. Sun, and N.N. Tandon Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation Thromb. Haemost. 87 2002 728 734
27. N. Gervasoni, J.M. Aubry, G. Bondolfi, C. Osiek, M. Schwald, G. Bertschy, and F. Karege Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode Neuropsychobiology 51 2005 234 238
28. I. Grande, F. Kapczinski, L. Stertz, G.D. Colpo, M. Kunz, K.M. Cereser, M. Kauer-Sant'Anna, B. Frey, E. Vieta, and P.V. Magalhaes Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: an open-label trial in drug-free patients with bipolar disorder J. Psychiatr. Res. 46 2012 1511 1514
29. M.E. Greenberg, B. Xu, B. Lu, and B.L. Hempstead New Insights in the Biology of BDNF Synthesis and Release: Implications in CNS Function J. Neurosci. 29 2009 12764 12767
30. J.O. Groves Is it time to reassess the BDNF hypothesis of depression? Mol. Psychiatry 12 2007 1079 1088
31. L.A. Harker, L.K. Roskos, U.M. Marzec, R.A. Carter, J.K. Cherry, B. Sundell, E.N. Cheung, D. Terry, and W. Sheridan Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers Blood 95 2000 2514 2522
32. Higgins, J.P.T., Green, S. (Eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org
33. T.L. Huang, Y.Y. Hung, C.T. Lee, and R.F. Chen Serum protein levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in bipolar disorder: effects of mood stabilizers Neuropsychobiology 65 2012 65 69
34. T.L. Huang, C.T. Lee, and Y.L. Liu Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants J. Psychiatr. Res. 42 2008 521 525
35. H.-Y. Lee, and Y.-K. Kim Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants Neuropsychobiology 57 2008 194 199
36. P.Y. Lin State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study Neurosci. Lett. 466 2009 139 143
37. M.L. Molendijk, B.A.A. Bus, P. Spinhoven, A. Kaimatzoglou, R.C.O. Voshaar, B.W.J.H. Penninx, M.H. van Ijzendoorn, and B.M. Elzinga A systematic review and meta-analysis on the association between bdnf val(66)met and hippocampal volume-a genuine effect or a winners curse? Am. J. Med. Genet. Part B-Neuropsychiatr. Genet. 159B 2012 731 740
38. M.L. Molendijk, P. Spinhoven, M. Polak, B.A. Bus, B.W. Penninx, and B.M. Elzinga Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484) Mol. Psychiatry 19 7 2014 791 800
39. P. Monteleone, C. Serritella, V. Martiadis, and M. Maj Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders Bipolar Disord. 10 2008 95 100
40. J.W. Murrough, and D.S. Charney Is there anything really novel on the antidepressant horizon? Curr. Psychiatry Rep. 14 2012 643 649
41. T. Nakahashi, H. Fujimura, C.A. Altar, J. Li, J. Kambayashi, N.N. Tandon, and B. Sun Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor FEBS Lett. 470 2000 113 117
42. S. Nakajima, T. Suzuki, K. Watanabe, H. Kashima, and H. Uchida Accelerating response to antidepressant treatment in depression: a review and clinical suggestions Prog. Neuro-Psychopharmacol. Biol. Psychiatry 34 2010 259 264
43. The Global Burden of Disease: 2004 Update 2008 WHO Geneva, Switzerland
44. A. Palomino, A. Vallejo-Illarramendi, A. Gonzalez-Pinto, A. Aldama, C. Gonzalez-Gomez, F. Mosquera, G. Gonzalez-Garcia, and C. Matute Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients Schizophr. Res. 86 2006 321 322
45. W. Pan, W.A. Banks, M.B. Fasold, J. Bluth, and A.J. Kastin Transport of brain-derived neurotrophic factor across the blood-brain barrier Neuropharmacology 37 1998 1553 1561
46. W.M. Pardridge, Y.S. Kang, and J.L. Buciak Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery Pharm. Res. 11 1994 738 746
47. A. Piccinni, D. Marazziti, M. Catena, L. Domenici, A. Del Debbio, C. Bianchi, C. Mannari, C. Martini, E. Da Pozzo, E. Schiavi, A. Mariotti, I. Roncaglia, A. Palla, G. Consoli, L. Giovannini, G. Massimetti, and L. Dell'Osso Plasma and serum brain-derived neurotrophic factor depressed patients during 1 year of antidepressant (BDNF) in treatments J. Affect. Disord. 105 2008 279 283
48. S.F. Radka, P.A. Holst, M. Fritsche, and C.A. Altar Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay Brain Res. 709 1996 122 130
49. P.S. Rojas, R. Fritsch, R.A. Rojas, P. Jara, and J.L. Fiedler Serum brain-derived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: a pilot study Psychiatry Res. 189 2011 239 245
50. R.D. Rosenfeld, L. Zeni, N. Haniu, J. Talvenheimo, S.F. Radka, L. Bennett, J.A. Miller, and A.A. Welcher Purification and identification of brain-derived neurotrophic factor from human serum Protein Expr. Purif. 6 1995 465 471
51. M.L. Schroeter, H. Abdul-Khaliq, M. Krebs, A. Diefenbacher, and I.E. Blasig Serum markers support disease-specific glial pathology in major depression J. Affect. Disord. 111 2008 271 280
52. M.L. Schroeter, and J. Steiner Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders Mol. Psychiatry 14 2009 235 237
53. M.L. Schroeter, J. Steiner, and K. Mueller Glial pathology is modified by age in mood disorders-a systematic meta-analysis of serum S100B in vivo studies J. Affect. Disord. 134 2011 32 38
54. S. Sen, R.S. Duman, and G. Sanacora Meta-analysis of serum brain-derived neurotrophic factor (BDNF) levels in depression and antidepressant treatment Biol. Psychiatry 63 2008 (98S-98S)
55. R.T. Sousa, M.T. Van De But, B.S. Diniz, R.B. Ladeira, L.V. Portela, D.O. Souza, O.V. Forlenza, W.F. Gattaz, and R. Machado-Vieira Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a 4-week study Biol. Psychiatry 69 2011 (132S-132S)
56. A.T. Suehs B, S.D. Bendele, M.L. Crimson, M.H. Trivedi, and B. Kurian Texas Medication Algorithm Project Procedural Manual Major Depressive Disorder Algorithms 2008 Texas Department of State health Services Texas
57. A. Tadic, S. Wagner, K.F. Schlicht, D. Peetz, L. Borysenko, N. Dreimuller, C. Hiemke, and K. Lieb The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study Prog Neuropsychopharmacol. Biol. Psychiatry 35 2011 415 420
58. S. Tamura, A. Nagasawa, Y. Masuda, T. Tsunematsu, K. Hayasaka, K. Matsuno, C. Shimizu, Y. Ozaki, and T. Moriyama BDNF, produced by a TPO-stimulated megakaryocytic cell line, regulates autocrine proliferation Biochem. Biophys. Res. Commun. 427 2012 542 546
59. S.J. Taylor, and.R.L. Tweedie Practical estimates of the effect of publication bias in meta-analysis Aust. Epidemiol. 5 1998 14 17
60. S.G. Thompson, and J.P.T. Higgins How should meta-regression analyses be undertaken and interpreted? Stat. Med. 21 2002 1559 1573
61. V. Trajkovska, A.B. Marcussen, M. Vinberg, P. Hartvig, S. Aznar, and G.M. Knudsen Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data Brain Res. Bull. 73 2007 143 149
62. J.F. Tramontina, A.C. Andreazza, M. Kauer-Sant'anna, L. Stertz, J. Goi, F. Chiarani, and F. Kapczinski Brain-derived neurotrophic factor serum levels before and after treatment for acute mania Neurosci. Lett. 452 2009 111 113
63. S. Tsuchimine, N. Sugawara, M. Ishioka, and N. Yasui-Furukori Preanalysis storage conditions influence the measurement of brain-derived neurotrophic factor levels in peripheral blood Neuropsychobiology 69 2014 83 88
64. W. Umene-Nakano, R. Yoshimura, A. Ikenouchi-Sugita, H. Hori, K. Hayashi, N. Ueda, and J. Nakamura Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence Hum. Psychopharmacol. Clin. Exp. 24 2009 409 413
65. J. Undurraga, and R.J. Baldessarini Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review Neuropsychopharmacology 37 2012 851 864
66. H. Yamamoto, and M.E. Gurney Hsuman platelets contain brain-derived neurotrophic factor J. Neurosci. 10 1990 3469 3478
67. R. Yoshimura, A. Ikenouchi-Sugita, H. Hori, W. Umene-Nakano, A. Katsuki, K. Hayashi, N. Ueda, and J. Nakamura Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression Prog. Neuro-Psychopharmacol. Biol. Psychiatry 34 2010 308 312
68. R. Yoshimura, A. Ikenouchi-Sugita, H. Hori, W. Umene-Nakano, A. Katsuki, K. Hayashi, N. Ueda, and J. Nakamura Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression Prog. Neuropsychopharmacol. Biol. Psychiatry 34 2010 308 312
69. R. Yoshimura, M. Mitoma, A. Sugita, H. Hori, T. Okamoto, W. Umene, N. Ueda, and J. Nakamura Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients Prog. Neuro-Psychopharmacol. Biol. Psychiatry 31 2007 1034 1037
70. R. Yoshimura, Y. Nakano, H. Hori, A. Ikenouchi, N. Ueda, and J. Nakamura Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders Hum. Psychopharmacol. 21 2006 433 438
71. R. Yoshimura, A. Sugita-Ikenouchi, H. Hori, W. Umene-Nakano, K. Hayashi, A. Katsuki, N. Ueda, and J. Nakamura A close correlation between plasma and serum levels of brain-derived neurotrophic factor (BDNF) in healthy volunteers Int. J. Psychiatry Clin. 14 2010 220 222
72. J.M. Zajecka Treating depression to remission J. Clin. Psychiatry 64 Suppl. 15 2003 S7 S12